Literature DB >> 22836217

Fibrinogen Tokushima II: a new case of congenital dysfibrinogenemia with a γ methionine-310 to threonine substitution.

Toshio Shigekiyo, Etsuko Sekimoto, Atsuhisa Shirakami, Hiroshi Yamaguchi, Hironobu Shibata, Shuji Ozaki, Masahiko Maegawa, Ken-ichi Aihara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22836217     DOI： 10.1007/s12185-012-1148-0

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  10 in total

1.  Mode of perturbation of Asahi fibrin assembly by the extra oligosaccharides.

Authors:  T Sugo; O Sekine; C Nakamikawa; H Endo; C L Arocha-Piñango; M Matsuda
Journal:  Ann N Y Acad Sci       Date:  2001       Impact factor: 5.691

Review 2.  The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation.

Authors:  P H B Bolton-Maggs; D J Perry; E A Chalmers; L A Parapia; J T Wilde; M D Williams; P W Collins; S Kitchen; G Dolan; A D Mumford
Journal:  Haemophilia       Date:  2004-09       Impact factor: 4.287

3.  Hypofibrinogenemia associated with a heterozygous missense mutation gamma153Cys to arg (Matsumoto IV): in vitro expression demonstrates defective secretion of the variant fibrinogen.

Authors:  F Terasawa; N Okumura; K Kitano; N Hayashida; M Shimosaka; M Okazaki; S T Lord
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

Review 4.  gamma-Chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in the gamma chain of human fibrinogen.

Authors:  H C Côté; S T Lord; K P Pratt
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

Review 5.  Fibrinogen replacement therapy for congenital fibrinogen deficiency.

Authors:  L Bornikova; F Peyvandi; G Allen; J Bernstein; M J Manco-Johnson
Journal:  J Thromb Haemost       Date:  2011-09       Impact factor: 5.824

6.  Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defects.

Authors:  Wolfgang Miesbach; Inge Scharrer; Agnes Henschen; Marguerite Neerman-Arbez; Silvia Spitzer; Dennis Galanakis
Journal:  Blood Coagul Fibrinolysis       Date:  2010-01       Impact factor: 1.276

7.  A gamma methionine-310 to threonine substitution and consequent N-glycosylation at gamma asparagine-308 identified in a congenital dysfibrinogenemia associated with posttraumatic bleeding, fibrinogen Asahi.

Authors:  K Yamazumi; K Shimura; S Terukina; N Takahashi; M Matsuda
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

8.  Pharmacokinetics and safety of fibrinogen concentrate.

Authors:  M J Manco-Johnson; D Dimichele; G Castaman; S Fremann; S Knaub; U Kalina; F Peyvandi; G Piseddu; P Mannucci
Journal:  J Thromb Haemost       Date:  2009-10-05       Impact factor: 5.824

Review 9.  Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.

Authors:  F Haverkate; M Samama
Journal:  Thromb Haemost       Date:  1995-01       Impact factor: 5.249

10.  Fibrinogen Yecheon: congenital dysfibrinogenemia with gamma methionine-310 to threonine substitution.

Authors:  Eunkyung Park; Geumbore Park; Rojin Park; Hee-Jin Kim; Sang Jae Lee; Young Joo Cha
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.